Bitcoin halving
What does that mean?
$2.76T
Total marketcap
$110.44B
Total volume
BTC 49.83%     ETH 15.32%
Dominance

Johnson & Johnson JNJB34.SA Stock

53.01 BRL {{ price }} 0.875355% {{change_pct}}%
COUNTRY
Brazil
Exchange
São Paulo
Market Cap
1.92T BRL
LOW - HIGH [24H]
52.55 - 53.05 BRL
VOLUME [24H]
4.92K BRL
{{ volume }}
P/E Ratio
30.64
Earnings per share
1.73 BRL

Johnson & Johnson Price Chart

Johnson & Johnson JNJB34.SA Financial and Trading Overview

Johnson & Johnson stock price 53.01 BRL
Previous Close 50.31 BRL
Open 0 BRL
Bid 50.5 BRL x 0
Ask 51.2 BRL x 0
Day's Range 0 - 0 BRL
52 Week Range 0 - 65.5 BRL
Volume 0 BRL
Avg. Volume 12.96K BRL
Market Cap 1.84T BRL
Beta (5Y Monthly) 0.573
PE Ratio (TTM) 29.045715
EPS (TTM) 1.73 BRL
Forward Dividend & Yield 1.43 (2.81%)
Ex-Dividend Date November 20, 2023
1y Target Est N/A

JNJB34.SA Valuation Measures

Enterprise Value 130.03B BRL
Trailing P/E 29.045715
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 18.618105
Price/Book (mrq) 1.7178102
Enterprise Value/Revenue 1.318
Enterprise Value/EBITDA 3.714

Trading Information

Johnson & Johnson Stock Price History

Beta (5Y Monthly) 0.573
52-Week Change N/A
S&P500 52-Week Change N/A
52 Week High 65.5 BRL
52 Week Low 0 BRL
50-Day Moving Average 50.27 BRL
200-Day Moving Average 52.58 BRL

JNJB34.SA Share Statistics

Avg. Volume (3 month) 12.96K BRL
Avg. Daily Volume (10-Days) 8.05K BRL
Shares Outstanding 36.11B
Float 2.4B
Short Ratio N/A
% Held by Insiders 0%
% Held by Institutions 0.0020%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 4.64
Trailing Annual Dividend Yield 9.22%
5 Year Average Dividend Yield 238.00%
Payout Ratio 0.8561
Last Split Factor 15:1

Financial Highlights

Fiscal Year

Fiscal Year Ends January 1, 2023
Most Recent Quarter (mrq) October 1, 2023
Next Fiscal Year End January 1, 2024

Profitability

Profit Margin 35.09%
Operating Margin (ttm) 30.07%
Gross Margin 67.55%
EBITDA Margin 35.49%

Management Effectiveness

Return on Assets (ttm) 10.11%
Return on Equity (ttm) 19.18%

Income Statement

Revenue (ttm) 98.66B BRL
Revenue Per Share (ttm) 2.56 BRL
Quarterly Revenue Growth (yoy) 6.80%
Gross Profit (ttm) 63.95B BRL
EBITDA 35.01B BRL
Net Income Avi to Common (ttm) 13.99B BRL
Diluted EPS (ttm) 1.75
Quarterly Earnings Growth (yoy) 483.80%

Balance Sheet

Total Cash (mrq) 23.51B BRL
Total Cash Per Share (mrq) 9.77 BRL
Total Debt (mrq) 29.92B BRL
Total Debt/Equity (mrq) 42.01 BRL
Current Ratio (mrq) 1.21
Book Value Per Share (mrq) 29.59

Cash Flow Statement

Operating Cash Flow (ttm) 20.28B BRL
Levered Free Cash Flow (ttm) 21.17B BRL

Profile of Johnson & Johnson

Country Brazil
State NJ
City New Brunswick
Address One Johnson & Johnson Plaza
ZIP 08933
Phone 732 524 0400
Website https://www.jnj.com
Industry Drug Manufacturers-General
Sector(s) Healthcare
Full Time Employees 152700

Johnson & Johnson, together with its subsidiaries, researches, develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment provides skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; TYLENOL acetaminophen products; SUDAFED cold, flu, and allergy products; BENADRYL and ZYRTEC allergy products; MOTRIN IB ibuprofen products; NICORETTE smoking cessation products; and PEPCID acid reflux products. This segment also offers STAYFREE and CAREFREE sanitary pads; o.b. tampons; adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. It serves general public, retail outlets, and distributors. The company's Pharmaceutical segment provides products for rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; HIV/AIDS infectious diseases; mood disorders, neurodegenerative disorders, and schizophrenia; prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; thrombosis, diabetes, and macular degeneration; and pulmonary arterial hypertension. This segment serves retailers, wholesalers, distributors, hospitals, and healthcare professionals directly for prescription use. Its MedTech segment offers electrophysiology products to treat cardiovascular diseases; neurovascular care products to treat hemorrhagic and ischemic stroke; orthopaedics products in support of hips, knees, trauma, spine, sports, and other; advanced and general surgery solutions that focus on breast aesthetics, ear, nose, and throat procedures; and contact lenses and ophthalmic technologies related to cataract and laser refractive surgery under the ACUVUE brand. This segment serves wholesalers, hospitals, and retailers. Johnson & Johnson was founded in 1886 and is based in New Brunswick, New Jersey.

Q&A For Johnson & Johnson Stock

What is a current JNJB34.SA stock price?

Johnson & Johnson JNJB34.SA stock price today per share is 53.01 BRL.

How to purchase Johnson & Johnson stock?

You can buy JNJB34.SA shares on the São Paulo exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Johnson & Johnson?

The stock symbol or ticker of Johnson & Johnson is JNJB34.SA.

Which industry does the Johnson & Johnson company belong to?

The Johnson & Johnson industry is Drug Manufacturers-General.

How many shares does Johnson & Johnson have in circulation?

The max supply of Johnson & Johnson shares is 36.15B.

What is Johnson & Johnson Price to Earnings Ratio (PE Ratio)?

Johnson & Johnson PE Ratio is 30.64161700 now.

What was Johnson & Johnson earnings per share over the trailing 12 months (TTM)?

Johnson & Johnson EPS is 1.73 BRL over the trailing 12 months.

Which sector does the Johnson & Johnson company belong to?

The Johnson & Johnson sector is Healthcare.